These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3836746)

  • 41. Antibody response and clinical reactions in children given measles vaccine with immunoglobulin.
    Lingam S; Miller CL; Clarke M; Pateman J
    Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1044-5. PubMed ID: 3083994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measles vaccination. VII. Follow-up studies in children immunized with four doses of inactivated vaccine.
    Norrby E; Lagercantz R; Gard S
    Acta Paediatr Scand; 1969 May; 58(3):261-7. PubMed ID: 5783412
    [No Abstract]   [Full Text] [Related]  

  • 43. Antibody response and clinical reactions in children given measles vaccine with immunoglobulin.
    Elliman D
    Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1597-8. PubMed ID: 3087532
    [No Abstract]   [Full Text] [Related]  

  • 44. Measles vaccination. V. The booster effect of purified hemagglutinin in children previously immunized with this product or formalin-killed vaccine.
    Norrby E; Lagercrantz R; Gard S
    Acta Paediatr Scand; 1966 Jan; 55(1):73-8. PubMed ID: 5919475
    [No Abstract]   [Full Text] [Related]  

  • 45. [A comparative study of live measles vaccines in controlled epidemiologic trials].
    Donchev D; Arabadzhieva Ts; Zhukovets V; Iancheva B
    Vopr Virusol; 1969; 14(1):104-7. PubMed ID: 4894054
    [No Abstract]   [Full Text] [Related]  

  • 46. [Atypical measles experienced in 1970].
    Seki T; Hara M; Miyazaki Y; Chiba H; Yokota K
    Nihon Shonika Gakkai Zasshi; 1971 Jun; 75(6):440-5. PubMed ID: 5104630
    [No Abstract]   [Full Text] [Related]  

  • 47. [Atypical measles with hepatic involvement].
    Riaño Galán I; Alonso Villa MJ; Cimadevilla Suárez R; Martínez Gutiérrez A
    An Esp Pediatr; 1992 May; 36(5):399-400. PubMed ID: 1616204
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparative trial of further attenuated measles vaccines.
    Hendrickse RG; Montefiore D; Sherman P; Peradze T
    Br Med J; 1966 Mar; 1(5490):779-81. PubMed ID: 5910109
    [No Abstract]   [Full Text] [Related]  

  • 49. Determination of measles immunity after a mass immunization campaign.
    Levitt LP; Case GE; Neil JS; Casey HL; Adler P; Ferreri S; Witte JJ
    Public Health Rep (1896); 1970 Mar; 85(3):261-5. PubMed ID: 4984891
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pediatric immunization advice bureau. Is hazard-free measles vaccination of children with Lowe syndrome possible?].
    Wiersbitzky S; Bruns R; Dammenhayn P; Wüstenberg H
    Kinderarztl Prax; 1989 Aug; 57(8):405-6. PubMed ID: 2796129
    [No Abstract]   [Full Text] [Related]  

  • 51. [Measles].
    Kaganov BS
    Feldsher Akush; 1986 Jan; 51(1):13-7. PubMed ID: 3633817
    [No Abstract]   [Full Text] [Related]  

  • 52. [Immunologic structure of the population characterizing measles susceptibility and its change with massive active immunization].
    Tsipershtein MIa; Shekhter AB
    Zh Mikrobiol Epidemiol Immunobiol; 1972 May; 49(5):39-42. PubMed ID: 5037761
    [No Abstract]   [Full Text] [Related]  

  • 53. Antibody titres three years after immunization with a live measles vaccine.
    Schumacher H; Welbers de Liddle IB
    Ger Med Mon; 1971; 1(1):37-41. PubMed ID: 5579592
    [No Abstract]   [Full Text] [Related]  

  • 54. Measles and absence of Koplik spots in vaccinated children.
    Aksit S; Caglayan S; Ozdogru E; Kansdy S
    Paediatr Perinat Epidemiol; 1994 Oct; 8(4):455-6. PubMed ID: 7870628
    [No Abstract]   [Full Text] [Related]  

  • 55. The immunization of children in the Lagos area against measles.
    Njoku-Obi AN; Ogunbi O
    J Trop Pediatr (1967); 1967 Sep; 13(3):96-101. PubMed ID: 5299220
    [No Abstract]   [Full Text] [Related]  

  • 56. Further field testing of the more heat-stable measles vaccines in Cameroon.
    Heymann DL; Smith EL; Nakano JH; Jato JG; Martin GE; Maben GK
    Br Med J (Clin Res Ed); 1982 Aug; 285(6341):531-3. PubMed ID: 6809158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A study of the immunologic activity of the live measles vaccine developed by the Academy of Medical Sciences of the USSR from strain EShCh].
    Voroshilova MK; Chumakov MP; Siniak KM; Ralko LP; Romanenko VF; Rodin VI; Karaseva IA; Khozinskiĭ VI; Seĭbil' VB; Zaprometova LV; Turakhodzhaeva RZ; Urin AI; Chudnaia LM
    Vopr Virusol; 1967; 12(4):415-9. PubMed ID: 5611747
    [No Abstract]   [Full Text] [Related]  

  • 58. Further attenuated live measles vaccines: the need for revised recommendations.
    Krugman RD; Rosenberg R; McIntosh K; Herrmann K; Witte JJ; Ennis FA; Meyer BC
    J Pediatr; 1977 Nov; 91(5):766-7. PubMed ID: 561839
    [No Abstract]   [Full Text] [Related]  

  • 59. The atypical-measles syndrome.
    Lancet; 1979 May; 1(8123):962-3. PubMed ID: 87625
    [No Abstract]   [Full Text] [Related]  

  • 60. Vaccination against measles in the Canadian Arctic.
    Furesz J; Habgood M
    JAMA; 1966 Jan; 195(5):342-4. PubMed ID: 5951890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.